Navigation Links
Vestara and MedClean Technologies Announce Co-Marketing Partnership to Expand Innovative Solution for Pharmaceutical Waste Management
Date:9/21/2009

Vestara announced today a co-marketing agreement with MedClean Technologies (OTC:BB: MCLN), a premier provider of innovative technology and services for the onsite treatment of and disposal of regulated medical waste. Both Vestara and MedClean Technologies believe this strategic partnership will further expand operations and better provide the healthcare industry with the most effective, automated solution that addresses pharmaceutical waste management to control increasing costs and facilitate environmental responsibility.

Irvine, CA (PRWEB) September 21, 2009 -- Vestara announced today a co-marketing agreement with MedClean Technologies (OTC:BB: MCLN), a premier provider of innovative technology and services for the onsite treatment of and disposal of regulated medical waste.

Both Vestara and MedClean Technologies believe this strategic partnership will further expand operations and better provide the healthcare industry with the most effective, automated solution that addresses pharmaceutical waste management to control increasing costs and facilitate environmental responsibility.

Vestara's EcoRex® Automated Pharmaceutical Waste Management System utilizes barcode technology already widely used in hospitals to track drug utilization that prevents medication errors and a proprietary, continuously updated database of more than 180,000 National Drug Code (NDC) products, to instantly categorize pharmaceutical waste at time of presentation. By automating the identification and sorting of different types of residual drugs, empty containers, and each hospital's unique admixtures, EcoRex® eliminates the human error and potential cross contamination inherent in manual sorting of pharmaceutical waste to reduce negative impact on the environment. Just as important, relevant data and an audit trail are provided in the form of comprehensive reports for client records.

MedClean® Series Systems enable hospitals and other medical facilities to treat and dispose of their RMW stream and provide HIPAA-compliant destruction of confidential documents in an efficient, compliant, safe and cost-effective manner. MedClean provides a state-of-the-art on-site treatment solution for each end user through its full line of On-Demand Container, Mobile and in-house, fixed systems. MedClean's solutions provide significant advantages for hospital customers compared to other approaches, including lower costs, reduced risk and protection of host communities and the overall environment. A single MedClean Container system can treat 1 million pounds of RMW per year, in addition to handling confidential document destruction, with a smaller footprint required compared to multiple vendors handling different tasks for a hospital.

Working together, Vestara and MedClean bring unique technologies to a common customer base, addressing the toughest waste mitigation issues facing hospitals today.

Please visit booth # 419 at the 2009 ASHES Conference in Reno, NV, September 21-22, 2009, to learn more about the Vestara-MedClean Technologies partnership.

About Vestara
Vestara, headquartered in Irvine, CA, provides proprietary technology to automatically identify, sort, and segregate hazardous and non-hazardous pharmaceutical waste into proper waste streams. Vestara's solutions not only assure clients will be compliant with all federal and state laws, but that they will experience a more efficient health system workforce and true cost savings in managing pharmaceutical waste. Most importantly, clients will play a critical role in preserving our precious environment. To learn more, visit www.vestara.com.

About MedClean Technologies, Inc.
MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further, information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

# # #

Read the full story at http://www.prweb.com/releases/2009/09/prweb2870584.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Vestara Announces Agreement with Leading Environmental "Champion for Change" Company Amerinet
2. MedClean Technologies Inc. Announces New Ticker Symbol
3. MedClean Technologies Inc. CEO Publishes Letter to Shareholders
4. MedClean Technologies, Inc. Announces $1 Million Order
5. MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract
6. MedClean Technologies, Inc. Approved in New Jersey
7. MedClean Technologies Announces Results of Private Exchange Offer
8. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
9. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
10. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
11. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & ... by Moonlight to raise money for the American Heart Association Heart Walk. Teams of ... will work together to keep their treadmills moving for 5 hours. Treadmills will start ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017 West Pharmaceutical Services, Inc. ... injectable drug administration, today announced that it will release ... Thursday, October 26, 2017, and will follow with a ... at 9:00 a.m. Eastern Time. To participate on the ... conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ... Aspen Surgical facility in Las Piedras, Puerto ... scalpels and blades. ... that the facility sustained minor structural damage, temporary loss ... Maria. Repairs have been completed, manufacturing operations have resumed, ...
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
Breaking Medicine Technology: